From: Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial
Parameter and Criteria
Odds Ratio
95% CI of Odds Ratio
GSRS-D Reduction From Baseline of 0.33 (n = 50)
5.55
(1.17–26.26)
p = .031
Kidney Peritubular Capillary GL-3 Reduction From Baseline > 0.1